Pacific Biosciences of California PACB Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Pacific Biosciences of California's total liabilities?
- Pacific Biosciences of California (PACB) reported total liabilities of $780M in Q1 2026.
- What is the long-term trend for Pacific Biosciences of California's total liabilities?
- Over 5 years (2020 to 2025), Pacific Biosciences of California's total liabilities has grown at a 58.2% compound annual growth rate (CAGR), from $78.49M to $778.73M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.